Epigenetic modulation with nanosatellite triggers tumoricidal immunity for hepatocellular carcinoma treatment



Summary

Researchers have developed a novel approach to treat hepatocellular carcinoma (HCC) by combining epigenetic modulation with nanosatellite delivery to trigger an anti-tumor immune response. The system utilizes nanosatellites to deliver epigenetic drugs that alter gene expression within HCC cells. This reprogramming process enhances the presentation of tumor-associated antigens, making the cancer cells more recognizable to the immune system. Simultaneously, the nanosatellites release immunostimulatory signals, further activating immune cells like T cells to target and destroy the HCC cells. This dual-pronged approach leverages epigenetic changes and immune activation for a potentially more effective and targeted HCC therapy.

Read more…

Credits: Source

This post is part of “Science/Immunology News”, Follow for more…!!!